X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (29225) 29225
Magazine Article (392) 392
Newsletter (371) 371
Newspaper Article (179) 179
Book Chapter (16) 16
Conference Proceeding (14) 14
Book / eBook (13) 13
Dissertation (13) 13
Web Resource (12) 12
Streaming Video (8) 8
Book Review (2) 2
Reference (2) 2
Transcript (2) 2
Government Document (1) 1
Publication (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28627) 28627
anti-hiv agents - therapeutic use (25471) 25471
hiv infections - drug therapy (21197) 21197
female (14393) 14393
male (13331) 13331
adult (11907) 11907
infectious diseases (10227) 10227
hiv (10074) 10074
middle aged (7167) 7167
immunology (6689) 6689
antiretroviral therapy (5936) 5936
hiv infections - virology (5811) 5811
viral load (5471) 5471
aids (5007) 5007
cd4 lymphocyte count (4952) 4952
antiviral agents (4695) 4695
hiv infection (4483) 4483
drug therapy, combination (4427) 4427
human immunodeficiency virus--hiv (4365) 4365
anti-hiv agents - administration & dosage (4339) 4339
hiv-1 - drug effects (4235) 4235
anti-hiv agents - adverse effects (4209) 4209
virology (3974) 3974
antiretroviral therapy, highly active (3749) 3749
drug therapy (3692) 3692
anti-hiv agents - pharmacology (3565) 3565
treatment outcome (3556) 3556
pharmacology & pharmacy (3516) 3516
hiv infections - complications (3482) 3482
hiv infections - immunology (3429) 3429
hiv infections - prevention & control (3422) 3422
hiv infections - epidemiology (3215) 3215
highly active antiretroviral therapy (3153) 3153
adolescent (3124) 3124
reverse transcriptase inhibitors - therapeutic use (3015) 3015
aids/hiv (2966) 2966
health aspects (2924) 2924
hiv-1 (2918) 2918
risk factors (2909) 2909
human-immunodeficiency-virus (2860) 2860
infection (2827) 2827
hiv-1 - genetics (2769) 2769
research (2742) 2742
microbiology (2733) 2733
antiretroviral drugs (2686) 2686
hiv infections - transmission (2682) 2682
pregnancy (2644) 2644
young adult (2580) 2580
therapy (2564) 2564
public, environmental & occupational health (2247) 2247
cohort studies (2176) 2176
care and treatment (2174) 2174
acquired immune deficiency syndrome--aids (2168) 2168
prevention (2121) 2121
anti-hiv agents (2092) 2092
zidovudine - therapeutic use (2064) 2064
acquired immunodeficiency syndrome - drug therapy (2054) 2054
child (1977) 1977
human immunodeficiency virus (1966) 1966
hiv protease inhibitors - therapeutic use (1899) 1899
analysis (1897) 1897
retrospective studies (1869) 1869
protease inhibitors (1843) 1843
medicine, general & internal (1811) 1811
active antiretroviral therapy (1803) 1803
hiv patients (1785) 1785
aged (1783) 1783
prevalence (1781) 1781
hiv/aids (1720) 1720
mortality (1716) 1716
rna, viral - blood (1698) 1698
infectious disease transmission, vertical - prevention & control (1693) 1693
adherence (1625) 1625
patient compliance (1593) 1593
animals (1578) 1578
research article (1578) 1578
time factors (1548) 1548
zidovudine (1525) 1525
infant, newborn (1521) 1521
prospective studies (1514) 1514
drug resistance, viral (1510) 1510
mutation (1506) 1506
infant (1482) 1482
virus diseases (1435) 1435
tenofovir (1433) 1433
drug resistance (1428) 1428
hiv infections - diagnosis (1418) 1418
cross-sectional studies (1405) 1405
medicine (1403) 1403
hiv infections - psychology (1396) 1396
anti-hiv agents - pharmacokinetics (1384) 1384
lamivudine - therapeutic use (1374) 1374
hiv-1 - physiology (1346) 1346
infections (1345) 1345
antiretroviral agents (1317) 1317
immunodeficiency-virus type-1 (1315) 1315
pregnancy complications, infectious - drug therapy (1295) 1295
disease progression (1268) 1268
child, preschool (1256) 1256
genotype (1248) 1248
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (28553) 28553
Spanish (532) 532
French (412) 412
German (398) 398
Chinese (111) 111
Japanese (78) 78
Russian (68) 68
Portuguese (63) 63
Dutch (50) 50
Italian (41) 41
Hebrew (15) 15
Polish (15) 15
Danish (14) 14
Norwegian (14) 14
Finnish (7) 7
Czech (5) 5
Serbian (5) 5
Turkish (5) 5
Hungarian (3) 3
Korean (2) 2
Romanian (2) 2
Swedish (2) 2
Bulgarian (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science (American Association for the Advancement of Science), ISSN 1095-9203, 2010, Volume 329, Issue 5996, pp. 1168 - 1174
.... HIV serostatus, safety, sexual behavior, and gel and condom use were assessed at monthly follow-up visits for 30 months... 
Human sexual behavior | HIV infections | Antiinfectives | Gels | HIV | RESEARCH ARTICLES | Placebos | Experimentation | AIDS | Infections | Condoms | VAGINAL GEL | INDIVIDUALS | SOUTH-AFRICA | PROPHYLAXIS | IN-VITRO | TRANSMISSION | MULTIDISCIPLINARY SCIENCES | CLINICAL-TRIALS | MALE CIRCUMCISION | RANDOMIZED CONTROLLED-TRIAL | CHALLENGES | HIV Infections - prevention & control | Anti-Infective Agents, Local - therapeutic use | Urban Population - statistics & numerical data | HIV Infections - epidemiology | Humans | Anti-Infective Agents, Local - adverse effects | Drug Resistance, Viral | Administration, Intravaginal | Viral Load | Incidence | Anti-HIV Agents - administration & dosage | Tenofovir | Young Adult | Adenine - adverse effects | HIV-1 - physiology | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Vaginal Creams, Foams, and Jellies | Rural Population - statistics & numerical data | Sexual Behavior | Adenine - analogs & derivatives | Double-Blind Method | Organophosphonates - therapeutic use | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | South Africa - epidemiology | Organophosphonates - adverse effects | Adenine - administration & dosage | Pregnancy | Organophosphonates - administration & dosage | Anti-Infective Agents, Local - administration & dosage | Adolescent | Patient Compliance | Pregnancy Outcome | Prevention | Anti-infective agents | Research | HIV infection
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 08/2015, Volume 22, Issue 24, pp. 2819 - 2857
Heterocyclic N-oxides have emerged as potent compounds with anticancer, antibacterial, antihypertensive, antiparasitic, anti-HIV, anti-inflammatory,... 
Antichagasic agents | Heterocyclic N-oxides | Bioisosteres | Factor xa inhibitors | Antimalarials | Hypoxia | Nitric oxide mimics | Coagulation cascade direct thrombin inhibitors | hypoxia | TRANSITION-METAL CATALYSIS | BETA-AMINOESTER CLASS | CHEMISTRY, MEDICINAL | ACTIVATED PROTEIN-KINASE | antichagasic agents | K-ATP CHANNELS | BIOCHEMISTRY & MOLECULAR BIOLOGY | antimalarials | HUMAN-LEUKOCYTE ELASTASE | coagulation cascade direct thrombin inhibitors | CARBON BOND FORMATION | 1,3-DIOXIDE CORE SCAFFOLDS | HIV-1 ENTRY INHIBITORS | PHARMACOLOGY & PHARMACY | bioisosteres | factor Xa inhibitors | LONG-TERM POTENTIATION | FACTOR XA INHIBITOR | nitric oxide mimics | Anti-HIV Agents - pharmacology | Neuroprotective Agents - therapeutic use | Antihypertensive Agents - pharmacology | Humans | Antineoplastic Agents - therapeutic use | Herbicides - pharmacology | Antihypertensive Agents - therapeutic use | Anti-Bacterial Agents - therapeutic use | Fibrinolytic Agents - pharmacology | Cyclic N-Oxides - therapeutic use | Animals | Neuroprotective Agents - pharmacology | Cyclic N-Oxides - pharmacology | Protein Kinase Inhibitors - therapeutic use | Fibrinolytic Agents - therapeutic use | Anti-HIV Agents - therapeutic use | Anti-Bacterial Agents - pharmacology | Antineoplastic Agents - pharmacology | Protein Kinase Inhibitors - pharmacology
Journal Article
Gastroenterology, ISSN 0016-5085, 2012, Volume 142, Issue 6, pp. 1324 - 1334.e3
With the development of effective therapies against human immunodeficiency virus (HIV), hepatitis C virus (HCV) infection has become a major cause of morbidity... 
Gastroenterology and Hepatology | Drug Interaction | HCV | Treatment | HIV | Liver Disease | ANTIRETROVIRAL THERAPY | RANDOMIZED CONTROLLED-TRIAL | HUMAN-IMMUNODEFICIENCY-VIRUS | NATURAL-HISTORY | LIVER-DISEASE | SEXUAL TRANSMISSION | HEPATITIS-C VIRUS | ALPHA-2A PLUS RIBAVIRIN | GENOTYPE 1 INFECTION | PEGYLATED INTERFERON-ALPHA-2B | GASTROENTEROLOGY & HEPATOLOGY | Recombinant Proteins - therapeutic use | Coinfection | Antiviral Agents - pharmacokinetics | HIV Infections - epidemiology | Humans | Hepatitis C, Chronic - etiology | Male | Polyethylene Glycols - therapeutic use | Oligopeptides - therapeutic use | Serine Proteinase Inhibitors - therapeutic use | Tenofovir | Deoxycytidine - therapeutic use | Drug Interactions | Homosexuality, Male | Adenine - therapeutic use | Lamivudine - therapeutic use | Anti-HIV Agents - therapeutic use | Dideoxynucleosides - therapeutic use | Hepatitis C, Chronic - epidemiology | Drug Therapy, Combination | Raltegravir Potassium | Substance Abuse, Intravenous - complications | Emtricitabine | Liver Diseases - virology | Antiviral Agents - pharmacology | Adenine - analogs & derivatives | Drug Administration Schedule | Organophosphonates - therapeutic use | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Liver Diseases - prevention & control | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Pyrrolidinones - therapeutic use | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Disease Progression | Proline - therapeutic use | HIV Infections - etiology | Liver Cirrhosis - virology | Antiviral Agents - adverse effects | HIV Infections - drug therapy | Deoxycytidine - analogs & derivatives | Antiviral agents | Medical colleges | Care and treatment | Liver diseases | Comorbidity | Drug interactions | Mortality | Development and progression | Biological response modifiers | HIV (Viruses) | Hepatitis | Protease inhibitors | Proteases | Hepatitis C virus | Hepatitis C | Health aspects | HIV infection | Index Medicus | Abridged Index Medicus
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 09/2011, Volume 18, Issue 25, pp. 3825 - 3852
The chemistry of chromones is very well known. This system is widely used in organic chemistry as an intermediate compound for the synthesis of numerous... 
Mast cell stabilizers | Benzopyran-4-ones | Occurrence | Biological activity | Chromones | STELLERA-CHAMAEJASME L | CHEMISTRY, MEDICINAL | biological activity | mast cell stabilizers | BIOCHEMISTRY & MOLECULAR BIOLOGY | benzopyran-4-ones | DNA-BINDING PROPERTIES | occurrence | CONCENTRATING HORMONE-RECEPTOR-1 ANTAGONISTS | ANTI-HIV AGENTS | BENZOYL HYDRAZONE | ALDOSE REDUCTASE INHIBITORS | CHEMICAL-CONSTITUENTS | ANTIBACTERIAL ACTIVITY | LN(III) COMPLEXES | PHARMACOLOGY & PHARMACY | POTENTIAL ANTIINFLAMMATORY AGENTS | Plant Extracts - chemistry | Anti-Infective Agents - isolation & purification | Antioxidants - chemistry | Plant Extracts - pharmacology | Anti-Infective Agents - pharmacology | Humans | Anti-Infective Agents - chemistry | Enzyme Inhibitors - chemistry | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - isolation & purification | Plants - chemistry | Antineoplastic Agents, Phytogenic - therapeutic use | Chromones - pharmacology | Chromones - therapeutic use | Anti-Inflammatory Agents - pharmacology | Enzyme Inhibitors - pharmacology | Anti-Infective Agents - therapeutic use | Antineoplastic Agents, Phytogenic - chemistry | Plant Extracts - isolation & purification | Antioxidants - pharmacology | Enzyme Inhibitors - therapeutic use | Enzyme Inhibitors - isolation & purification | Neoplasms - drug therapy | Chromones - chemistry | Antioxidants - therapeutic use | Animals | Anti-Inflammatory Agents - chemistry | Antioxidants - isolation & purification | Chromones - isolation & purification | Antineoplastic Agents, Phytogenic - pharmacology | Plant Extracts - therapeutic use | Antineoplastic Agents, Phytogenic - isolation & purification
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 229 - 237
Summary Background The non-nucleoside reverse transcriptase inhibitor (NNRTI), rilpivirine (TMC278; Tibotec Pharmaceuticals, County Cork, Ireland), had... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | ZIDOVUDINE | COMBINATION THERAPY | ACTIVE ANTIRETROVIRAL THERAPY | EMTRICITABINE | PROTEASE-INHIBITOR | CYSTATIN-C | CREATININE | DAILY LAMIVUDINE | NEVIRAPINE | TENOFOVIR | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Nucleotides - therapeutic use | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Nucleosides - therapeutic use | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Evaluation | Patient outcomes | Clinical trials | Dosage and administration | Drug therapy | HIV infection | Design | Antiretroviral drugs | Corporate sponsorship | Human immunodeficiency virus--HIV | Technological change | Research | Clinical medicine | Drugs | RNA-directed DNA polymerase | Exanthema | antiretroviral therapy | Lamivudine | Lipids | Nucleotides | Regression analysis | Efavirenz | CD4 antigen | nucleosides | Algorithms | Hospitals | non-nucleoside reverse transcriptase inhibitors | Abacavir | Zidovudine | Pharmaceuticals
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 2014, Volume 58, Issue 7, pp. 928 - 936
Background. Several combinations of 2 or 3 direct-acting antivirals (DAAs) can cure hepatitis C virus (HCV) in the majority of treatment-naive patients. DAAs... 
Antiretrovirals | HIV | Cost estimates | Antivirals | Raw material costs | Raw materials | ARTICLES AND COMMENTARIES | Hepatitis C | Dosage | Hepacivirus | Production costs | sofosbuvir | faldaprevir | ribavirin | simeprevir | daclatasvir | INFECTIOUS DISEASES | MICROBIOLOGY | IMMUNOLOGY | POTENT | BI 201335 | INHIBITOR | ANTIRETROVIRAL TREATMENT | Heterocyclic Compounds, 3-Ring - economics | Simeprevir | Oligopeptides - economics | Hepatitis C - drug therapy | Ribavirin - economics | Humans | Imidazoles - chemistry | Uridine Monophosphate - chemistry | Uridine Monophosphate - economics | Thiazoles - therapeutic use | Health Services Accessibility - economics | Oligopeptides - therapeutic use | Antiviral Agents - chemistry | Drug Industry - economics | Imidazoles - therapeutic use | Drug Therapy, Combination | Oligopeptides - chemistry | Thiazoles - economics | Uridine Monophosphate - therapeutic use | Sulfonamides - chemistry | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Ribavirin - chemistry | Anti-HIV Agents - chemistry | Sulfonamides - therapeutic use | Imidazoles - economics | Heterocyclic Compounds, 3-Ring - chemistry | Heterocyclic Compounds, 3-Ring - therapeutic use | Sulfonamides - economics | Uridine Monophosphate - analogs & derivatives | Thiazoles - chemistry | Developing Countries | Antiviral Agents - economics | Sofosbuvir | Economic aspects | Antiviral agents | Production management | Care and treatment | and Commentaries
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2015, Volume 15, Issue 7, pp. 775 - 784
Summary Background Problems associated with lifelong antiretroviral therapy, such as need for strict adherence, drug-related toxic effects, difficulties with... 
Infectious Disease | INFECTIOUS DISEASES | ABACAVIR-LAMIVUDINE | EFFICACY | SAFETY | NAIVE HIV-1-INFECTED PATIENTS | ACTIVE ANTIRETROVIRAL THERAPY | ONCE-DAILY ATAZANAVIR/RITONAVIR | TWICE-DAILY LOPINAVIR/RITONAVIR | INFECTED PATIENTS | PROTEASE INHIBITORS | TENOFOVIR | HIV-1 | Humans | Middle Aged | Male | RNA, Viral - blood | Viral Load | Oligopeptides - therapeutic use | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Deoxycytidine - therapeutic use | Drug Therapy, Combination - adverse effects | Adenine - therapeutic use | Lamivudine - therapeutic use | Atazanavir Sulfate | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Pyridines - therapeutic use | Emtricitabine | HIV Protease Inhibitors - adverse effects | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Anti-HIV Agents - adverse effects | HIV Infections - virology | HIV Protease Inhibitors - therapeutic use | Drug Therapy, Combination - methods | HIV Infections - drug therapy | Zidovudine - therapeutic use | Drug Substitution | Deoxycytidine - analogs & derivatives | Studies | Antiretroviral drugs | Heart attacks | Protease inhibitors | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Clinical trials | Infections | Mutation | Drug therapy | Failure | Cost control | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9738, pp. 367 - 387
Summary HIV-infected drug users have increased age-matched morbidity and mortality compared with HIV-infected people who do not use drugs... 
Internal Medicine | SOFT-TISSUE INFECTIONS | MEDICINE, GENERAL & INTERNAL | OPIOID SUBSTITUTION TREATMENT | HEPATITIS-C VIRUS | SMOKING-CESSATION PHARMACOTHERAPIES | CLINICAL-TRIAL | TREATMENT OUTCOMES | METHADONE-MAINTENANCE | ADMINISTERED ANTIRETROVIRAL THERAPY | RANDOMIZED CONTROLLED-TRIAL | HUMAN-IMMUNODEFICIENCY-VIRUS | HIV Infections - epidemiology | Humans | Drug Resistance, Bacterial | Narcotics - therapeutic use | Criminal Law | Anti-HIV Agents - administration & dosage | Hepatitis, Viral, Human - epidemiology | Drug Interactions | Antipsychotic Agents - therapeutic use | Substance-Related Disorders - epidemiology | Tuberculosis - drug therapy | Anti-HIV Agents - therapeutic use | HIV Infections - mortality | Substance-Related Disorders - mortality | Antitubercular Agents - therapeutic use | Mental Disorders - epidemiology | Antiviral Agents - therapeutic use | Bacterial Infections - drug therapy | Comorbidity | AIDS-Related Opportunistic Infections - drug therapy | Evidence-Based Medicine | Narcotics - administration & dosage | Medication Adherence | Mental Disorders - drug therapy | AIDS-Related Opportunistic Infections - epidemiology | Bacterial Infections - epidemiology | HIV Infections - drug therapy | Substance-Related Disorders - drug therapy | Hepatitis, Viral, Human - drug therapy | Prisoners | Prevention | Complications and side effects | Drug addicts | Research | Drug therapy | Health aspects | HIV infection | Mental illness | Risk factors | Cardiovascular diseases
Journal Article